These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 20843413)

  • 1. Turning off the spigot: reducing drug-resistant tuberculosis transmission in resource-limited settings.
    Nardell E; Dharmadhikari A
    Int J Tuberc Lung Dis; 2010 Oct; 14(10):1233-43. PubMed ID: 20843413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework.
    Pablos-Mendez A; Gowda DK; Frieden TR
    Bull World Health Organ; 2002; 80(6):489-95; discussion 495-500. PubMed ID: 12132008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing the spread of multidrug-resistant tuberculosis and protecting contacts of infectious cases.
    Fox GJ; Schaaf HS; Mandalakas A; Chiappini E; Zumla A; Marais BJ
    Clin Microbiol Infect; 2017 Mar; 23(3):147-153. PubMed ID: 27592087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for halting the rise of multidrug resistant TB epidemics: assessing the effect of early case detection and isolation.
    Espindola AL; Varughese M; Laskowski M; Shoukat A; Heffernan JM; Moghadas SM
    Int Health; 2017 Mar; 9(2):80-90. PubMed ID: 28338827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment as prevention and other interventions to reduce transmission of multidrug-resistant tuberculosis.
    Nathavitharana RR; Lederer P; Tierney DB; Nardell E
    Int J Tuberc Lung Dis; 2019 Apr; 23(4):396-404. PubMed ID: 31064617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of treating multidrug-resistant tuberculosis.
    Resch SC; Salomon JA; Murray M; Weinstein MC
    PLoS Med; 2006 Jul; 3(7):e241. PubMed ID: 16796403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of difficult multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: update 2012.
    Chang KC; Yew WW
    Respirology; 2013 Jan; 18(1):8-21. PubMed ID: 22943408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-Resistant tuberculosis - primary transmission and management.
    Outhred AC; Britton PN; Marais BJ
    J Infect; 2017 Jun; 74 Suppl 1():S128-S135. PubMed ID: 28646952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical management of adults and children with multidrug-resistant and extensively drug-resistant tuberculosis.
    Dheda K; Chang KC; Guglielmetti L; Furin J; Schaaf HS; Chesov D; Esmail A; Lange C
    Clin Microbiol Infect; 2017 Mar; 23(3):131-140. PubMed ID: 27756712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High incidence of hospital admissions with multidrug-resistant and extensively drug-resistant tuberculosis among South African health care workers.
    O'Donnell MR; Jarand J; Loveday M; Padayatchi N; Zelnick J; Werner L; Naidoo K; Master I; Osburn G; Kvasnovsky C; Shean K; Pai M; Van der Walt M; Horsburgh CR; Dheda K
    Ann Intern Med; 2010 Oct; 153(8):516-22. PubMed ID: 20956708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A national infection control evaluation of drug-resistant tuberculosis hospitals in South Africa.
    Farley JE; Tudor C; Mphahlele M; Franz K; Perrin NA; Dorman S; Van der Walt M
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):82-9. PubMed ID: 22236851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Treatment Cost on Transmission of Multidrug-Resistant Tuberculosis Into Iran.
    Bialvaei AZ; Kafil HS; Asgharzadeh M
    Clin Infect Dis; 2015 Sep; 61(6):1029-30. PubMed ID: 26060290
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost of multi drug resistance tuberculosis in Germany.
    Diel R; Nienhaus A; Lampenius N; Rüsch-Gerdes S; Richter E
    Respir Med; 2014 Nov; 108(11):1677-87. PubMed ID: 25443398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical and affordable measures for the protection of health care workers from tuberculosis in low-income countries.
    Harries AD; Maher D; Nunn P
    Bull World Health Organ; 1997; 75(5):477-89. PubMed ID: 9447782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug-resistant and extensively drug-resistant tuberculosis: a review.
    Chan ED; Iseman MD
    Curr Opin Infect Dis; 2008 Dec; 21(6):587-95. PubMed ID: 18978526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time to put boots on the ground: making universal access to MDR-TB treatment a reality.
    Keshavjee S; Farmer PE
    Int J Tuberc Lung Dis; 2010 Oct; 14(10):1222-5. PubMed ID: 20843411
    [No Abstract]   [Full Text] [Related]  

  • 17. Better than a pound of cure: preventing the development of multidrug-resistant tuberculosis.
    Byrne AL; Fox GJ; Marais BJ
    Future Microbiol; 2018 Apr; 13():577-588. PubMed ID: 29521120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Availability, price and affordability of anti-tuberculosis drugs in Europe: a TBNET survey.
    Günther G; Gomez GB; Lange C; Rupert S; van Leth F;
    Eur Respir J; 2015 Apr; 45(4):1081-8. PubMed ID: 25395035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a standardised multidrug-resistant/extensively drug-resistant tuberculosis assessment and monitoring tool.
    Migliori GB; Sotgiu G; Jaramillo E; Mirzayev F; Centis R; Colvin C; Richardson MD
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1305-8. PubMed ID: 19793438
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.